If there’s just one message Sandals Resorts International Executive Chairman Adam Stewart wants to relay to travel advisors in the aftermath of Hurricane Melissa, it is this: Sandals properties — and ...
Jamaica's hospitality sector is facing an uneven recovery following Hurricane Melissa, with some resorts already welcoming back guests while others in harder-hit regions face lengthy reopening ...
This is a recurring article that is being regularly updated with new information. Hurricane Melissa swept across the Caribbean as a catastrophic Category 5 storm last week, leaving a path of ...
The rationale behind N.B. Power’s controversial decision to build a gas-fired power plant on a 550-acre woodlot is outlined in a recent report from the utility, but critics aren’t buying it. In ...
Sandals Resorts International (SRI) on Tuesday announced that it will begin welcoming guests back to Jamaica on Saturday, December 6, 2025, at its resorts in Ocho Rios and Negril after ensuring its ...
Sandals Resorts has outlined its resort reopening plans. It hopes to start welcoming guests from December 6 at Sandals Dunn’s River, Sandals Ochi, Sandals Royal Plantation, Sandals Negril, and Beaches ...
After assessing the damage wrought by Hurricane Melissa to its eight Jamaican properties, Sandals and Beaches Resorts plan to reopen properties in Ocho Rios and Negril – Sandals Dunn’s River, Sandals ...
Sandals and Beaches Resorts have revealed three of their Jamaica properties will remain closed for seven months in the aftermath of Hurricane Melissa, with the other five properties set to reopen next ...
Following Hurricane Melissa's impact last week, Sandals Resorts International has announced plans to reopen five of its Jamaica resorts on Dec. 6. The December reopenings include the Sandals Dunn's ...
MONTEGO BAY, JAMAICA — Sandals Resorts International (SRI) has announced plans to reopen five of its resorts in Jamaica following the impacts of Hurricane Melissa, with properties in Ocho Rios and ...
LONDON and MILAN, Nov. 03, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results